Capabilities in Small
Molecules & DMPK
Capabilities in Small Molecules & DMPK
ADME Services
  • Physicochemical property
  • Metabolic stability
  • Distribution
  • Permeability and transporter
  • Drug-drug interaction (DDI)
  • Customized assays
  • High Quality of Physicochemical Property Evaluation
     
    Kinetic Solubility
    In PBS, SGF, SIF
    Thermodynamic Solubility
    In PBS, SGF, SIF
    Chemical
    Stability
    In PBS, SGF, SIF
    Log D at pH7.4
    In PBS, SGF, SIF
    Early Formulation Screening
    In PBS, SGF, SIF
  • Metabolic Stability with Variety of Capabilities
     
    Microsomal
    Human
    ICR mouse, SD rat
    Beagle dog
    Cynomolgus monkey
    Hepatocyte
    Human
    ICR mouse, SD rat
    Beagle dog
    Cynomolgus monkey
    Plasma
    Human
    ICR mouse, SD rat
    Beagle dog
    Cynomolgus monkey
    Whole blood
    ICR mouse
    SD rat
    Stability challenges following oral administration
  • Distribution Services with Reliable Results
     
  • Reliable Permeability and Transporter Assays
     
     
  • ADME Services for Drug-Drug Interaction(DDI)
     
    CYP Inhibitor Substrate Reaction Metabolite
    1A2 α-NAphthoflavon Phenacetin Phenacetin O-Deethylation Acetaminophen
    2B6 Clopidogrel Bupropion Bupropion-Hydroxylation Hydroxybupropion
    2C8 Nicardipine Paclitaxel Paclitaxel 6α-Hydroxylation 6α-Hydroxy PAclitaxel
    2C9 Sulfaphenazole Diclofenac Diclofenac 4'-Hydroxylation 4'-Hydroxy Diclofenac
    2C19 Omerazole S-MEphenytoin s-MEphenytoin 4'-Hydroxylation 4-HYdroxy MEphenytoin
    2D6 Quinidine Dextromethorphan Dextromethorphan O-Demethylation Dextrorphan
    3A4-T Ketoconazole Testosterone Testosterone 6β-Hydroxylation 6β-Hydroxy TEstosterone
    3A4-M Ketoconazole Midazolam Midazolam 1-Hydroxylation Mida1'-Hydroxy MIdazolam 
  • PK Services
    Rat PK
    Mouse BBB penetration
    Mouse PK: serial sampling
    Cassette dosing PK
    Mouse PK: parallel sampling
    Dog PK
    Rat BBB penetration
    MTD study
  • PK Services
     
    Animal
    Rodent, non-rodent
    Administration
    IV/SC/IM/IP/PO
    Samples
    Plasma, blood, CSF, bile, other fluids
    Tissue distribution
    Brain, CSF for BBB penetration; liver,kidney, lung etc.
    Excretion
    Fecal, urine, bile
    DDI
    ABT (CYP inhibitor)
    pH dependent
    Pentagastrin, Famotidine
    P-gp inhibition
    Verapamil
    Study Type Workflow (Days)
    Rat PK 5
    Mouse PK:serial
    sampling
    5
    Mouse PK:parallel sampling 5
    Rat BBB
    penetration#
    3
    Mouse BBB
    penetration#
    3
    Cassette dosing pk 5
    *standard pk with iv (1mpk), po (10 mpk), n=3# two time points for BBB penetration
  • CNS Distribution and PK Profiling
     
    Non-compartmental Analysis
    Parameter(IV)
    Lambda_z
    t1/2
    Tmax
    Cmax
    C0
    AUC 0-t
    AUC 0-inf_obs
    MRT 0-inf_obs
    Cl_obs
    Vss_obs
    Lambda_z
    Tmax
    C0
    AUC 0-inf_obs
    Cl_obs
    t1/2
    Cmax
    AUC 0-t
    MRT 0-inf_obs
    Vss_obs
    Parameter(PO)
    Lambda_z
    t1/2
    Tmax
    Cmax
     
    AUC 0-t
    AUC 0-inf_obs
    MRT 0-inf_obs
    Vz_obs
    F
    Lambda_z
    Tmax
     
    AUC 0-inf_obs
    Vz_obs
    t1/2
    Cmax
    AUC 0-t
    MRT 0-inf_obs
    F
    CNS exposure PK
    AUC brain
    Brain to plasma ratio
    Kp=AUC 0-t bRain/AUC 0-T plasma
    Kp,uu=(Cbrain/Cplasma)*(Fubrain/FuPlasma)
    Kp,uu
      1   Passive BBB diffusion
    <1   Efflux at BBB
    >1   Uptake at BBB
  • Experienced in Discrete and Cassette PK Studies
     
    Discrete Cassette
    Advantages Disadvantages Advantages Disadvantages
    w/o drug interactions Many animals used Reduction in animal usage Possible drug interactions
    w/o Iimitation on dose size Many biological samples to assay Reduction in analytical sample input Doses must be kept small
      Many reports   Complex LC-MS/MS method development
  • DMPK Research for Peptide
     
     
     
For more information about

Pharmacology & DMPK”, please contact our team.

Contact Us
Online Message
After receiving your message, our professional team will contact you shortly.
  • Area of Interest

    CRO Drug R&D Services

    CDMO R&D and Production Services

    EFS Investment&Incubation Business

    Media Cooperation

    Investor Relations

    Other

    How Did You Hear About Us?

    Search Engine (Google, Bing, Yahoo, etc)

    Conferences/Events

    Social Media

    LinkedIn

    Word of Mouth

    Other